Not all severe malaria cases are severe: Is it time to redefine severity criteria for malaria in non-endemic regions?


Journal

Travel medicine and infectious disease
ISSN: 1873-0442
Titre abrégé: Travel Med Infect Dis
Pays: Netherlands
ID NLM: 101230758

Informations de publication

Date de publication:
11 Jul 2024
Historique:
received: 09 05 2024
revised: 14 06 2024
accepted: 16 06 2024
medline: 14 7 2024
pubmed: 14 7 2024
entrez: 13 7 2024
Statut: aheadofprint

Résumé

The current definition of severe malaria in non-endemic areas follows WHO criteria, which mainly target children in malaria-endemic areas, potentially misclassifying cases in non-endemic regions. We assessed the performance of a modified severe malaria classification criteria within our patient cohort. A cohort study of patients managed for malaria in a non-endemic setting(2005-2023) was analyzed. We classified patients into severe malaria (SM) using WHO 2013 criteria except for hyperparasitemia, where 2% threshold was applied. Patients with SM were distinguished as very severe malaria(VSM) when presenting at least one of the following conditions: parasitemia >10%, pulmonary edema, impaired consciousness, seizures, renal failure, metabolic acidosis or hyperlactatemia, shock or hypoglycemia. In patients with SM and no criteria for VSM, less severe malaria(LSM) was defined by: 2-10% parasitemia, hyperbilirubinemia, prostration, anemia or minor bleeding. The primary composite outcome was death or the need for a life-saving intervention, as analyzed in the three comparative groups. Secondary outcome was the prevalence of co-infections. Among 506 patients with malaria, 176(34.8%) presented with SM. A total of 37(7.3%) patients developed a life-threatening condition, namely death (n=4) and/or the need for life-saving interventions(n=34). All fatalities and 33 out of the 34 life-saving interventions occurred in the VSM group. Patients in LSM group did not develop any life-threatening conditions. As to co-infections, 28(5.5%) patients had a community-acquired co-infection, with no differences between groups (p=0.763). Severity criteria definitions would benefit from a review when assessing patients with malaria in non-endemic areas. Within the spectrum of SM, patients reclassified as LSM have a low risk of developing a life-threatening condition and present low co-infection incidence and could benefit from management out of intensive care units and a restrictive use of empirical antibiotics.

Sections du résumé

BACKGROUND BACKGROUND
The current definition of severe malaria in non-endemic areas follows WHO criteria, which mainly target children in malaria-endemic areas, potentially misclassifying cases in non-endemic regions. We assessed the performance of a modified severe malaria classification criteria within our patient cohort.
METHODS METHODS
A cohort study of patients managed for malaria in a non-endemic setting(2005-2023) was analyzed. We classified patients into severe malaria (SM) using WHO 2013 criteria except for hyperparasitemia, where 2% threshold was applied. Patients with SM were distinguished as very severe malaria(VSM) when presenting at least one of the following conditions: parasitemia >10%, pulmonary edema, impaired consciousness, seizures, renal failure, metabolic acidosis or hyperlactatemia, shock or hypoglycemia. In patients with SM and no criteria for VSM, less severe malaria(LSM) was defined by: 2-10% parasitemia, hyperbilirubinemia, prostration, anemia or minor bleeding. The primary composite outcome was death or the need for a life-saving intervention, as analyzed in the three comparative groups. Secondary outcome was the prevalence of co-infections.
RESULTS RESULTS
Among 506 patients with malaria, 176(34.8%) presented with SM. A total of 37(7.3%) patients developed a life-threatening condition, namely death (n=4) and/or the need for life-saving interventions(n=34). All fatalities and 33 out of the 34 life-saving interventions occurred in the VSM group. Patients in LSM group did not develop any life-threatening conditions. As to co-infections, 28(5.5%) patients had a community-acquired co-infection, with no differences between groups (p=0.763).
CONCLUSIONS CONCLUSIONS
Severity criteria definitions would benefit from a review when assessing patients with malaria in non-endemic areas. Within the spectrum of SM, patients reclassified as LSM have a low risk of developing a life-threatening condition and present low co-infection incidence and could benefit from management out of intensive care units and a restrictive use of empirical antibiotics.

Identifiants

pubmed: 39002737
pii: S1477-8939(24)00056-5
doi: 10.1016/j.tmaid.2024.102740
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102740

Informations de copyright

Copyright © 2024. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Leire Balerdi-Sarasola (L)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain. Electronic address: leirebalerdisarasola@gmail.com.

Jose Muñoz (J)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Pedro Fleitas (P)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Natalia Rodriguez-Valero (N)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Alex Almuedo-Riera (A)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Alba Antequera (A)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Carme Subira (C)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Ignacio Grafia-Perez (I)

Medical Oncology Department, Hospital Clinic, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.

Maria Ortiz-Fernández (M)

Internal Medicine Department, Hospital Clínic- Universitat de Barcelona, Spain.

Tessa de Alba (T)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Miriam J Álvarez-Martínez (MJ)

Microbiology Department, Hospital Clinic-Universitat de Barcelona, Spain.

M Eugenia Valls (ME)

Microbiology Department, Hospital Clinic-Universitat de Barcelona, Spain.

Claudio Parolo (C)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Pedro Castro (P)

Medical Intensive Care Unit, Hospital Clínic- Universitat de Barcelona, Spain.

Daniel Camprubí-Ferrer (D)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Classifications MeSH